| 000 | 01821 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250514003726.0 | ||
| 264 | 0 | _c20010920 | |
| 008 | 200109s 0 0 eng d | ||
| 022 | _a0306-5251 | ||
| 024 | 7 |
_a10.1046/j.0306-5251.2001.bjcp.1399.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFowler, S J | |
| 245 | 0 | 0 |
_aDose-response for adrenal suppression with hydrofluoroalkane formulations of fluticasone propionate and beclomethasone dipropionate. _h[electronic resource] |
| 260 |
_bBritish journal of clinical pharmacology _cJul 2001 |
||
| 300 |
_a93-5 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Inhalation |
| 650 | 0 | 4 |
_aAdrenal Glands _xdrug effects |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAndrostadienes _xadministration & dosage |
| 650 | 0 | 4 |
_aAnti-Asthmatic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBeclomethasone _xadministration & dosage |
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 |
_aCreatinine _xurine |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFluticasone |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHydrocarbons, Fluorinated |
| 650 | 0 | 4 |
_aHydrocortisone _xurine |
| 650 | 0 | 4 |
_aLung _xmetabolism |
| 650 | 0 | 4 | _aNebulizers and Vaporizers |
| 650 | 0 | 4 | _aPharmaceutical Preparations |
| 650 | 0 | 4 | _aSingle-Blind Method |
| 700 | 1 | _aOrr, L C | |
| 700 | 1 | _aWilson, A M | |
| 700 | 1 | _aSims, E J | |
| 700 | 1 | _aLipworth, B J | |
| 773 | 0 |
_tBritish journal of clinical pharmacology _gvol. 52 _gno. 1 _gp. 93-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.0306-5251.2001.bjcp.1399.x _zAvailable from publisher's website |
| 999 |
_c11382224 _d11382224 |
||